title: ATM-dependent phosphorylation of nibrin in response to radiation exposure.
abstract: Mutations in the gene ATM are responsible for the genetic disorder ataxia-telangiectasia (A-T), which is characterized by cerebellar dysfunction, radiosensitivity, chromosomal instability and cancer predisposition. Both the A-T phenotype and the similarity of the ATM protein to other DNA-damage sensors suggests a role for ATM in biochemical pathways involved in the recognition, signalling and repair of DNA double-strand breaks (DSBs). There are strong parallels between the pattern of radiosensitivity, chromosomal instability and cancer predisposition in A-T patients and that in patients with Nijmegen breakage syndrome (NBS). The protein defective in NBS, nibrin (encoded by NBS1), forms a complex with MRE11 and RAD50 (refs 1,2). This complex localizes to DSBs within 30 minutes after cellular exposure to ionizing radiation (IR) and is observed in brightly staining nuclear foci after a longer period of time. The overlap between clinical and cellular phenotypes in A-T and NBS suggests that ATM and nibrin may function in the same biochemical pathway. Here we demonstrate that nibrin is phosphorylated within one hour of treatment of cells with IR. This response is abrogated in A-T cells that either do not express ATM protein or express near full-length mutant protein. We also show that ATM physically interacts with and phosphorylates nibrin on serine 343 both in vivo and in vitro. Phosphorylation of this site appears to be functionally important because mutated nibrin (S343A) does not completely complement radiosensitivity in NBS cells. ATM phosphorylation of nibrin does not affect nibrin-MRE11-RAD50 association as revealed by radiation-induced foci formation. Our data provide a biochemical explanation for the similarity in phenotype between A-T and NBS.
authors.affiliation: The Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Brisbane, Queensland, Australia.
authors.forename: M
authors.initials: M
authors.lastname: Gatei
authors.forename: D
authors.initials: D
authors.lastname: Young
authors.forename: K M
authors.initials: KM
authors.lastname: Cerosaletti
authors.forename: A
authors.initials: A
authors.lastname: Desai-Mehta
authors.forename: K
authors.initials: K
authors.lastname: Spring
authors.forename: S
authors.initials: S
authors.lastname: Kozlov
authors.forename: M F
authors.initials: MF
authors.lastname: Lavin
authors.forename: R A
authors.initials: RA
authors.lastname: Gatti
authors.forename: P
authors.initials: P
authors.lastname: Concannon
authors.forename: K
authors.initials: K
authors.lastname: Khanna
mesh_terms: D001260:Ataxia Telangiectasia / Q000201:enzymology / Q000235:genetics; D064007:Ataxia Telangiectasia Mutated Proteins; D018797:Cell Cycle Proteins / Q000235:genetics / Q000528:radiation effects*; D002460:Cell Line; D019457:Chromosome Breakage / Q000235:genetics; D004268:DNA-Binding Proteins; D005720:Gamma Rays; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D009687:Nuclear Proteins; D010766:Phosphorylation / Q000528:radiation effects; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000528:radiation effects*; D025521:Tumor Suppressor Proteins
chemical_list: D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; C112156:NBN protein, human; D009687:Nuclear Proteins; D025521:Tumor Suppressor Proteins; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases